(Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | (Q3)Sep 30, 2023 | (Q2)Jun 30, 2023 | (Q1)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q4)Dec 31, 2022 | (Q3)Sep 30, 2022 | |
---|---|---|---|---|---|---|---|---|---|---|
Operating Cash Flow (Indirect Method) | ||||||||||
Cash flow from continuing operating activities | -142.15%-1.45M | 9,591.07%1.48M | -186.52%-687.48K | -7.11%-907.37K | 288.58%804.66K | -136.30%-600.04K | -96.32%15.27K | 8.73%794.59K | -301.74%-847.1K | -229.68%-426.69K |
Net income from continuing operations | -82.85%191.32K | 121.42%122K | 1,271.40%6.66M | 853.88%6.01M | -71.42%99.7K | 947.30%1.12M | -4,843.17%-569.51K | -164.21%-568.46K | -253.53%-797.59K | 67.48%348.82K |
Operating gains losses | -119.32%-81.53K | -11.74%-131.26K | -7,266.74%-8.02M | -455.84%-8.25M | 53.64%-70.8K | 122.57%422.04K | 35.97%-117.47K | 121.34%111.84K | 1,224.47%2.32M | -274.18%-152.72K |
Depreciation and amortization | -14.32%45.53K | -19.97%41.64K | 6.20%221.37K | 13.49%58.86K | 9.11%57.34K | -6.17%53.14K | 9.80%52.02K | 19.00%208.44K | -2.44%51.87K | 19.64%52.55K |
Asset impairment expenditure | --0 | ---629 | 202.53%748.88K | 205.99%757.45K | --0 | ---8.57K | --0 | -69.77%247.54K | -69.78%247.54K | --0 |
Unrealized gains and losses of investment securities | 89.69%-104.3K | 177.16%95.77K | ---- | ---- | 151.99%296.11K | -152.82%-1.01M | -89.93%34.56K | ---- | ---- | -42.07%117.51K |
Remuneration paid in stock | 985.00%61.4K | -98.37%4.96K | -18.14%322.14K | -7.08%5.66K | -7.11%5.66K | -7.11%5.66K | -18.68%305.16K | 2,182.70%393.54K | 130.98%6.09K | 131.11%6.09K |
Other non cashItems | --0 | ---195K | -93.01%-354.12K | -107.44%-156.23K | ---188.76K | ---- | ---- | 61.79%-183.47K | 83.48%-75.31K | ---- |
Change In working capital | -34.11%-1.57M | 396.55%1.54M | -146.08%-269.65K | 91.76%-18.29K | 187.64%605.41K | -169.61%-1.17M | 273.59%310.51K | 756.54%585.17K | -142.60%-222.02K | -686.56%-690.78K |
-Change in receivables | 190.76%623.33K | -274.11%-1.47M | -81.48%50.83K | 112.39%1.48M | -143.82%-355K | -188.44%-686.77K | 80.50%-392.18K | 306.38%274.43K | -38.68%699.08K | 200.25%810.18K |
-Change in prepaid assets | -373.59%-1.31M | 638.28%1.96M | -181.64%-373.68K | -234.34%-1.17M | 171.96%802.71K | -136.28%-276.26K | -77.11%265.62K | 2,049.63%457.73K | 6.67%-348.67K | -512.03%-1.12M |
-Change in payables and accrued expense | -331.04%-880.41K | 139.78%1.05M | 136.20%53.21K | 41.07%-337.31K | 140.92%157.7K | -247.21%-204.25K | -34.97%437.07K | -187.51%-147K | -97.25%-572.43K | -188.03%-385.39K |
Cash from discontinued investing activities | ||||||||||
Operating cash flow | -142.15%-1.45M | 9,591.07%1.48M | -186.52%-687.48K | -7.11%-907.37K | 288.58%804.66K | -136.30%-600.04K | -96.32%15.27K | 8.73%794.59K | -301.74%-847.1K | -229.68%-426.69K |
Investing cash flow | ||||||||||
Cash flow from continuing investing activities | 87.52%-91.3K | 1,236.87%138.78K | -182.80%-1.92M | -103.17%-3.68K | -50.76%-1.17M | -123.42%-731.57K | 91.79%-12.21K | 422.14%2.32M | 206.91%115.95K | -256.15%-775.8K |
Net PPE purchase and sale | 2.37%-69.18K | -2,934.23%-58.41K | 40.88%-112.64K | 107.99%1.17K | -134.69%-41.02K | -4.59%-70.86K | 99.15%-1.93K | 16.53%-190.51K | 44.43%-14.59K | 1,144.31%118.27K |
Net business purchase and sale | ---- | ---- | ---18.86K | ---- | ---- | ---- | ---- | --0 | ---- | ---- |
Net investment purchase and sale | 183.08%86.01K | 159.57%272.53K | -92.33%267.18K | -6.95%178.36K | 134.25%87.35K | -103.13%-103.53K | -55.71%104.99K | 1,814.76%3.49M | 160.62%191.68K | -534.74%-255.02K |
Net other investing changes | 80.59%-108.13K | 34.64%-75.35K | -109.60%-2.05M | -168.78%-164.35K | -90.27%-1.22M | -365.13%-557.19K | 27.65%-115.28K | -45.63%-979.33K | 60.74%-61.15K | -141.00%-639.05K |
Cash from discontinued investing activities | ||||||||||
Investing cash flow | 87.52%-91.3K | 1,236.87%138.78K | -182.80%-1.92M | -103.17%-3.68K | -50.76%-1.17M | -123.42%-731.57K | 91.79%-12.21K | 422.14%2.32M | 206.91%115.95K | -256.15%-775.8K |
Financing cash flow | ||||||||||
Cash flow from continuing financing activities | 0 | 0 | -35.41%887.69K | 99.90%-78 | -34.01%872.89K | 7,828.28%18.86K | -103.02%-3.98K | 775.95%1.37M | -145.54%-80.32K | 20,375.87%1.32M |
Net issuance payments of debt | --0 | --0 | 62.64%-9.39K | 98.50%-78 | 75.08%-1.69K | 44.96%-3.64K | 39.27%-3.98K | 8.94%-25.14K | 36.31%-5.19K | -3.72%-6.77K |
Net common stock issuance | ---- | ---- | -30.98%888.3K | --0 | ---- | ---- | ---- | --1.29M | --0 | ---- |
Proceeds from stock option exercised by employees | ---- | ---- | -80.60%22.5K | --0 | --0 | ---- | ---- | -37.13%116K | -140.72%-75.13K | --46.13K |
Net other financing activities | ---- | ---- | -276.92%-13.72K | --0 | ---- | ---- | ---- | ---3.64K | --0 | ---- |
Cash from discontinued financing activities | ||||||||||
Financing cash flow | --0 | --0 | -35.41%887.69K | 99.90%-78 | -34.01%872.89K | 7,828.28%18.86K | -103.02%-3.98K | 775.95%1.37M | -145.54%-80.32K | 20,375.87%1.32M |
Net cash flow | ||||||||||
Beginning cash position | -1.03%9.39M | -18.09%7.77M | 89.58%9.49M | -15.70%8.68M | -19.69%8.18M | 75.58%9.49M | 89.58%9.49M | 3.49%5.01M | 128.01%10.3M | 130.69%10.18M |
Current changes in cash | -17.64%-1.54M | 174,842.98%1.62M | -138.29%-1.72M | -12.28%-911.13K | 322.24%507.98K | -127.48%-1.31M | -100.23%-926 | 2,553.51%4.48M | -266.36%-811.47K | 14.93%120.31K |
End cash Position | -4.03%7.85M | -1.03%9.39M | -18.09%7.77M | -18.09%7.77M | -15.70%8.68M | -19.69%8.18M | 75.58%9.49M | 89.58%9.49M | 89.58%9.49M | 128.01%10.3M |
Free cash from | -126.89%-1.52M | 10,776.63%1.39M | -276.41%-804.56K | -5.61%-910.04K | 267.31%763.63K | -142.32%-670.89K | -93.25%12.74K | -7.96%456.08K | -318.90%-861.69K | -243.66%-456.42K |
Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
Audit Opinions | -- | -- | Unqualified Opinion with Explanatory Notes | -- | -- | -- | -- | Unqualified Opinion | -- | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.